Belantamab mafodotin
Belantamab mafodotin (GSK2857916) is composed of humanized and focused monoclonal antibody against B cell maturation antigen (BCMA) and McMMAF. The antibody portion is Belantamab (HY-P9980), and the drug-linker conjugate for ADC is McMMAF (HY-15578) . Belantamab mafodotin has anti-myeloma activity[1][2].
Product Specifications
CAS Number
[2050232-20-5]
Product Name Alternative
GSK2857916; Belantamab mafodotin-blm
UNSPSC
12352203
Target
Antibody-Drug Conjugates (ADCs)
Type
ADC Related
Related Pathways
Antibody-drug Conjugate/ADC Related
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/belantamab-mafodotin.html
Purity
99.78
Solubility
10 mM in DMSO
Smiles
[Belantamabmafodotin]
Molecular Weight
149000 (average)
References & Citations
Shipping Conditions
Dry Ice
Storage Conditions
-80°C, protect from light
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-P3239/Belantamab-mafodotin-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-P3239/Belantamab-mafodotin-SDS-MedChemExpress.pdf
Scientific Category
ADC Related
Clinical Information
Launched
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
